Back to Search
MONIQUE BAER, MD
MD
Family Medicine Physician
NPI: 1720087406Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
34186(IA)
Research & Publications (20)
An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.
PMID 19103766·Infect Immun·2009
7-preclinical
Clinical significance of multidrug resistance in AML: current insights.
PMID 16555430·Clin Adv Hematol Oncol·2005
8-other
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
PMID 12149202·Blood·2002
3-trial
Detection of minimal residual disease in acute myeloid leukemia.
PMID 12162913·Curr Oncol Rep·2002
6-review
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
PMID 11369653·Blood·2001
8-other
Photodissociation of H2(+) upon exposure to an intense pulsed photonic Fock state.
PMID 19552475·J Phys Chem A·2009
8-other
The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes.
PMID 19204282·Proc Natl Acad Sci U S A·2009
7-preclinical
Intralines of quasi-conical intersections on torsion planes: methylamine as a case study.
PMID 19462985·J Phys Chem A·2009
8-other
Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment.
PMID 19271568·Cutis·2009
5-case
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
PMID 19671864·Clin Cancer Res·2009
3-trial
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
PMID 18976810·Leuk Res·2009
3-trial
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
PMID 19108889·Leuk Res·2009
3-trial
No confinement needed: observation of a metastable hydrophobic wetting two-layer ice on graphene.
PMID 19670866·J Am Chem Soc·2009
8-other
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
PMID 19528372·J Clin Oncol·2009
3-trial
Spectral signatures of the pentagonal water cluster in bacteriorhodopsin.
PMID 19025752·Chemphyschem·2008
8-other
Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
PMID 19018084·J Clin Oncol·2008
8-other
p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
PMID 19010910·Cancer Res·2008
8-other
Conformational dynamics of minimal elastin-like polypeptides: the role of proline revealed by molecular dynamics and nuclear magnetic resonance.
PMID 18972488·Chemphyschem·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15398 STACIE CT, DUBUQUE
DUBUQUE, IA 52002 - Phone
- (563) 542-7935
Quick Facts
- NPI
- 1720087406
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile